Evidence-Based Pharmacologic Treatment of Pediatric Bipolar Disorder
Evidence-Based Pharmacologic Treatment of Pediatric Bipolar Disorder
复制标题
DOI：
10.4088/jcp.15017su1c.02
复制
发表时间：
2016-01-01
影响因子：
5.3
通讯作者：
Findling, Robert L.
中科院分区：
文献类型：
--
作者：
Findling, Robert L.
Pharmacotherapy is an important component of treatment for children and adolescents with bipolar disorder. The body of evidence supporting safe and effective treatments in this population is growing. Available data provide information on the risks and benefits of pharmacologic agents used for acute manic, mixed, and depressive episodes as well as for maintenance treatment. Lithium, anticonvulsants, and antipsychotics comprise the armamentarium for treating pediatric bipolar disorder. When selecting treatment, clinicians must consider the efficacy and side effect profile of potential pharmacotherapies, as well as the patient's history, including the presence of comorbidities, in order to develop a treatment plan that will ensure optimal outcomes.
